Ken Anderson Basic and Translational Research Award
The Ken Anderson Basic and Translational Research Award was established by IMS to honor the seminal contributions of Professor Ken Anderson to bench to bedside translational research. This award is given to an investigator to recognize excellence in translational research in myeloma.
Recipient Profile
Professor Hervé Avet-Loiseau is Head of the Laboratory for Genomics in Myeloma in the University Cancer Center of Toulouse since September 2012. Before, he was head of the Hematology Laboratory of the University Hospital of Nantes, France, a position he has held since 2008. He received his medical degree with a specialization in Pediatric Hematology in 1990. After pursuing a postdoctoral fellowship in the laboratory of Dr. Joe Gray in San Francisco, he moved into the area of Biological Hematology in 1995 and subsequently specialized in cytogenetics. He received his PhD in 1998 and became Professor of Hematology in 2001. Professor Hervé Avet-Loiseau is highly involved in the Intergroupe Francophone du Myélome (IFM), past Chairman, where he leads all biological studies. Most of these studies are based on the analysis of genetic/genomic abnormalities observed in malignant plasma cells using different technologies, including Fluorescence In-Situ Hybridization (FISH), gene expression profiling, single nucleotide polymorphism (SNP) arrays, and Next Generation Sequencing (NGS).
Past Recipients
- 2017 – I. Ghobrial
- 2019 – C. Mitsiades
- 2021 – E. P. Neri
- 2022 – N. Raje
- 2023 – H. Avet-Loiseau
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
